Earnings History for Teva Pharmaceutical Industries Limited (TEVA)
|
Expand Research on TEVA
| Next EPS Date | 8/1/13 *Est. | EPS Growth Rate | -23.8% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +0.9% | Revenue Growth Rate | -3.9% *Last Qtr. |
| Average % Move 1-Wk after EPS | +0.6% |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Estimize EPS/Revs | Gd. | % Since | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
5/2/13  |
 |
Q113 | $1.12 | $1.10 | +$0.02 | $4.9B | $4.85B | N/A / N/A | N/A | +3.3% | Details |
| 2/7/13 |
|
Q412 | $1.32 | $1.33 | -$0.01 | $5.2B | $5.26B | N/A / N/A | N/A | +3.1% | Details |
| 11/1/12 |
|
Q312 | $1.28 | $1.25 | +$0.03 | $5B | $5.08B | N/A / N/A | = | +3.3% | Details |
| 8/2/12 |
|
Q212 | $1.28 | $1.28 | $0.00 | $5B | $5.08B | N/A / N/A | = | +3.3% | Details |
| 5/9/12 |
|
Q112 | $1.47 | $1.44 | +$0.03 | $5.1B | $5.51B | N/A / N/A | = | -11.5% | Details |
| 2/15/12 |
|
Q411 | $1.59 | $1.58 | +$0.01 | $5.68B | $5.61B | N/A / N/A | = | -9.6% | Details |
| 11/2/11 |
|
Q311 | $1.25 | $1.23 | +$0.02 | $4.34B | $4.54B | N/A / N/A | N/A | +0.7% | Details |
| 7/27/11 |
|
Q211 | $1.10 | $1.09 | +$0.01 | $4.21B | $4.24B | N/A / N/A | N/A | -15.9% | Details |
